Toward Development of Psychosocial Measures for Automated Insulin Delivery

Jill Weissberg-Benchell*, Korey Hood, Lori Laffel, Lutz Heinemann, Dana Ball, Aaron Kowalski, Anne Peters, Edward Damiano, Marie Schiller, Aaron Davis, Stayce Beck, Katharine Barnard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The INSPIRE study working group launched its initial workshop in February 2015 to facilitate collaboration among key stakeholders interested in automated insulin delivery (AID) systems and the psychosocial outcomes of individuals who may use these new technologies. Specifically, the INSPIRE team's goal is to facilitate measure development assessing the psychosocial factors associated with AID systems. A second working group was held to foster exchange among key stakeholders in AID system development. Patient, health care provider, engineering, industry, academic, regulatory and payer perspectives were presented. The INSPIRE working group will continue to serve as a platform to encourage open dialogue among all stakeholders with the aim of facilitating technology that offers minimal user burden and maximum benefit from both a psychological and physiologic perspective.

Original languageEnglish (US)
Pages (from-to)799-801
Number of pages3
JournalJournal of Diabetes Science and Technology
Volume10
Issue number3
DOIs
StatePublished - May 1 2016

Keywords

  • artificial pancreas
  • automated insulin delivery
  • diabetes technology
  • human factors
  • psychosocial

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Toward Development of Psychosocial Measures for Automated Insulin Delivery'. Together they form a unique fingerprint.

Cite this